pharma · Mild/non-serious osteoarthritis (OA) of the knee.
Haleon - Gebro
HALEON AUSTRALIA PTY LTD
Haleon - Gebro patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Fieberbrunn, AU HQ
179 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Fieberbrunn, AU
- Employees
- 179
- Programs
- 3
- Drugs
- 9
- Patents
- 0
Haleon - Gebro patents
0 pharmaceutical patents indexed for Haleon - Gebro. 0 expire within 24 months.
Haleon - Gebro has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Haleon - Gebro have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Haleon - Gebro patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.